Epidemiology and Population Health
Epidemiology is the study of the distribution, determinants, and control of illness and impairment in human populations. It is the cornerstone of population health and informs policy decisions and evidence-based medicine by identifying risk factors for disease and targets for treatment and prevention. The Department of Epidemiology and Population Health (EPH) provides the analytical foundation for research conducted at the Stanford School of Medicine, offering expertise, research, and training on collecting and interpreting the scientific evidence essential to improving human health.
The scholars within EPH conduct a wide variety of health-related research. Using observational and experimental research methods, our scholars uncover environmental, social, genetic, and behavioral factors to aid in human disease diagnosis, treatment, and prevention. Further, the faculty train physician investigators in techniques of clinical research and are committed to advancing knowledge in epidemiology and population health through educational programs for undergraduate, graduate, and postgraduate students.
How a Stanford study revealed the success of research failures
February 20, 2024 – Steven Goodman, EPH professor and leader of the Stanford Program on Research Rigor and Reproducibility, discusses the scientific benefits of failed experiments and the importance of research reproducibility.
In our own words: What Black History Month means to us
February 15, 2024 – EPH faculty, staff and students reflect on Black History Month and share some work focused on improving health equity in Black communities.
Healthy eating and activity reverse aging marker in kids with obesity
January 19, 2024 – A new study led by EPH professor David Rehkopf finds a genetic marker linked to premature aging was reversed in children with obesity during a six-month diet and exercise program.
New study finds metastatic breast cancer treatments have aided decline in deaths
January 17, 2024 – Dr. Allison Kurian, professor of medicine and of epidemiology and population health, is a co-senior author of a new study that finds deaths from breast cancer dropped 58% between 1975 and 2019 due to a combination of screening mammography and improvements in treatment.
Professor Langston presents cancer equity research to White House officials
Dec 20, 2023 – Dr. Marvin Langston was one of three Cancer Moonshot Scholars to present research alongside more than 40 federally-supported science and technology innovations at American Possibilities: A White House Demo Day, on November 7, 2023, in Washington DC.
The Cancer Moonshot Scholars program is designed to advance cancer science while also diversifying the pool of researchers and the approaches to cancer research that the NCI funds. Dr. Langston's project addresses tailored prostate cancer screening and addresses the USPSTF priority research gaps in a racially diverse study population.